Vaxart Shareholders Express Discontent Over Board's Choice to Postpone Reverse Stock Split Vote at Special Meeting
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 10 2025
0mins
Should l Buy ?
Source: Globenewswire
Concerns Over Board's Actions: Concerned Vaxart stockholders are criticizing the Board for repeatedly delaying the announcement of voting results regarding a proposed reverse stock split, which they believe is an attempt to manipulate stockholder support.
Demand for Transparency: The stockholders are calling for immediate transparency from the Board about the voting results, Nasdaq's compliance conditions, and any governance changes, expressing dissatisfaction with the Board's vague explanations and perceived disregard for stockholder rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
